Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T21:20:13.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T10:39:25.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T09:45:29.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The website has been updated to version 2.14.1, replacing the previous version 2.14.0.
    Difference
    0.1%
    Check dated 2025-01-20T00:36:01.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.3%
    Check dated 2025-01-12T19:26:26.000Z thumbnail image
  10. Check
    81 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-01-05T14:51:40.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.